You are here:

List of Tracks

Published on

Updated:

Your abstract or session must be submitted under one of the official tracks for the conference:

Note this is to assist with programme planning, track choice has no impact on the selection process.

 

TRACK A: BASIC AND TRANSLATIONAL RESEARCH

Scope for this track includes basic sciences, pre-clinical and product development for TB and other lung health conditions

A1. Immunology

A2. Drug and vaccine development, including for COVID-19

A3. TB diagnostics, including drug-resistance determination

A4. COVID-19: molecular and immuno diagnostics

 

TRACK B: CLINICAL AND OPERATIONAL RESEARCH

Scope for this track includes clinical trials, pragmatic trials, operational research on prevention, diagnosis and treatment of TB and other lung health conditions, including post-TB lung disease. Targeted populations may include children or any other age group, vulnerable sub-populations or people living with other co-morbidities.

B1. TB diagnostics

B2. Clinical trials and operational research for new treatments for drug sensitive-TB and drug resistant-TB in adults

B3. Clinical trials and operational research for COPD, pneumonia, asthma and other lung health in adults

B4. Clinical trials and operational research for new treatments for drug sensitive-TB and drug resistant-TB in children

B5. Clinical trials and operational research for COPD, pneumonia, asthma and other lung health in children

B6. Active case finding and contact investigation for TB

B7. Identification and management of TB infection

B8. TB and co-infections: including HIV and diabetes

B9. Lung health (other than TB) and co-morbidities

B10. Tobacco and co-morbidities: including NCDs, TB and HIV

B11. COVID-19: clinical and operational research

 

TRACK C: POLICIES AND CLINICAL & PROGRAMMATIC IMPLEMENTATION

Scope for this track includes the review and evaluation of global and local policies, clinical practices and programmatic implementation across the spectrum of prevention, diagnosis and treatment of TB and other lung health conditions, including post-TB lung disease; including research on improvement of current policies and practices

C1. TB infection (LTBI)

C2. TB care and treatment in drug sensitive-TB

C3. TB care and treatment in drug resistant-TB

C4. Paediatric TB treatment and care

C5. Paediatric lung disease, excluding TB

C6. Maternal and child health: TB and lung disease

C7. Post-TB lung health

C8. Person-centered care

C9. Access to quality TB care and services

C10. Global and local policies and politics, including funding and accountability

C11. TB laboratory service implementation and operations

C12. TB education and training

C13. Tobacco control and tobacco industry interference

C14. MPOWER for tobacco control

C15. COVID-19: policies and clinical implementation

 

TRACK D: EPIDEMIOLOGY

Scope for this track includes all aspects of epidemiology relating to TB, lung disease, tobacco control and co-morbidities such as HIV.

D1. TB epidemiology in adults

D2. TB epidemiology in children

D3. Epidemiology of COPD, pneumonia, asthma and other lung health conditions in adults

D4. Epidemiology of COPD, pneumonia, asthma and other lung health conditions in children

D5. Air pollution

D6. Epidemiology of transmission and TB infection

D7. TB infection control

D8. Post-TB lung health

D9. HIV-TB and other HIV-related lung health

D10. Modelling, including modelling of COVID-19: the effect of social controls, preparedness and lessons for other infectious diseases.

D11. Health economics

D12. Tobacco-related epidemiology

D13. E-cigarettes and non-combustible tobacco products

D14. COVID-19

 

TRACK E: POLITICS, CIVIL SOCIETY AND HUMAN RIGHTS

Scope includes research on and assessment of social, political, legal and human rights factors, stigma and discrimination influencing prevention, treatment, care and support for persons impacted by lung health issues, as well as communication of these issues to relevant stakeholders.

E1. Civil society, advocacy and community engagement

E2. Key affected populations: behavioural, social, and cultural issues and contexts

E3. Human rights

E4. Ethics

E5. Communication/social media

 

TRACK F: ZOONOTIC TB

Scope for this track includes studies on the epidemiology, prevention, diagnosis, and treatment challenges posed by zoonotic tuberculosis caused primarily by Mycobacterium bovis; to assist animal and public health agencies in more effectively controlling this disease and collaborating on field and laboratory research.

F1. Basic science and zoonotic diagnostics

F2. Zoonotic treatment

F3. Zoonotic epidemiology

F4. One Health